logo

Horizon Pharma Inc (HZNP)



Trade HZNP now with
  Date
  Headline
8/6/2020 11:31:12 PM Horizon Therapeutics Prices Public Offering Of 11.80 Mln Shares At $71.00/shr
8/5/2020 7:24:48 AM Horizon Therapeutics Q2 Net Loss $80 Mln Vs. Net Loss $5.1 Mln Last Year
6/3/2020 8:07:19 AM Horizon Therapeutics Reports Redemption Of All $400 Mln Of Its Exchangeable Senior Notes
5/14/2020 9:15:35 AM Horizon Therapeutics Announces New Data On The Pharmacokinetic Profile Of TEPEZZA
4/2/2020 8:06:40 AM Horizon Therapeutics Acquires Curzion Pharmaceuticals
2/26/2020 7:20:51 AM Horizon Therapeutics Q4 EPS $2.84; Non-GAAP EPS $0.56
1/23/2020 5:13:45 AM Horizon Therapeutics Secures FDA Approval For Teprotumumab For The Treatment Of Thyroid Eye Disease
11/6/2019 7:47:42 AM Horizon Therapeutics Q3 EPS $0.09 Vs. $0.19 Last Year
7/18/2019 9:04:51 AM Horizon Therapeutics: FDA Accepted NDA For PROCYSBI Oral Granules
7/10/2019 7:33:00 AM Horizon Therapeutics Subsidiary Horizon Pharma USA Intends To Offer $500 Mln Senior Notes Due 2027
7/10/2019 7:02:54 AM Horizon Therapeutics Submits Teprotumumab BLA For Treatment Of Active Thyroid Eye Disease
3/6/2019 10:08:22 PM Horizon Pharma Prices Underwritten Public Offering Of 12.24 Mln Shares At $24.50/shr
1/3/2019 8:14:13 AM Horizon Pharma, HemoShear Therapeutics Sign Exclusive Drug Discovery Collaboration In Gout